Market Recap — May 30, 2026
Recap of insider activity, SEC filings, and market-moving news for May 30, 2026.
Last generated Jul 14, 2026, 7:23 AM ET
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Dell's AI Server Revenue Soars 757% in Q1 Beat, Analysts Boost Price Targets
Cabometyx Shows Strong Efficacy, Reducing Progression/Death Risk by Up to 74% in Neuroendocrine Tumors
Immunome's Varegacestat Shows Statistically Significant Efficacy Across All Key Endpoints
Pfizer's Talzenna/Xtandi Combo Shows Over 50% Survival Improvement in Prostate Cancer Trial
Replimune's RP1 Shows Durable 3-Year Survival in Advanced Melanoma
Palomar Acquires Gray Surety, Raises 2026 Net Income Guidance
MicroStrategy Executives Signal Openness to Bitcoin Sales, Now Holds 843,738 BTC
Volkswagen to Review Elektros' Multi-Port EV Charging Patent
BioNTech & BMS Pumitamig Shows Encouraging Phase 2 Efficacy in NSCLC, High Response Rates Across PD-L1 Levels
Galleri Trial Shows 26% Reduction in Stage IV Cancer Diagnoses, Misses Primary Endpoint
Incyte's Monjuvi Combo Reduces Blood Cancer Progression by 25%, Targets Expanded First-Line Use Despite High Side Effects
ServiceNow Shares Jump 12-14% on AI Control Tower Enthusiasm, BofA Buy Rating
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
No open-market insider buys reported on this date.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
No open-market insider sells reported on this date.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
Dell's AI Server Revenue Soars 757% in Q1 Beat, Analysts Boost Price Targets
Cabometyx Shows Strong Efficacy, Reducing Progression/Death Risk by Up to 74% in Neuroendocrine Tumors
Immunome's Varegacestat Shows Statistically Significant Efficacy Across All Key Endpoints
Pfizer's Talzenna/Xtandi Combo Shows Over 50% Survival Improvement in Prostate Cancer Trial
Replimune's RP1 Shows Durable 3-Year Survival in Advanced Melanoma
Palomar Acquires Gray Surety, Raises 2026 Net Income Guidance
MicroStrategy Executives Signal Openness to Bitcoin Sales, Now Holds 843,738 BTC
Volkswagen to Review Elektros' Multi-Port EV Charging Patent
BioNTech & BMS Pumitamig Shows Encouraging Phase 2 Efficacy in NSCLC, High Response Rates Across PD-L1 Levels
Galleri Trial Shows 26% Reduction in Stage IV Cancer Diagnoses, Misses Primary Endpoint
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
No Form 144 notices filed on this date.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.